Research and Scientific Affairs
The Research and Scientific Affairs Department collects, analyzes and disseminates scientific data and information for members, AAOS staff, and external organizations to support the mission of the Academy. The department also supports the AAOS Council on Research and Quality and its associated committees and activities.
2014 Annual Meeting Scientific Exhibits
AAOS has been involved with the development of orthopaedic device standards through ASTM Committee F04 since its beginnings in 1962. Through ASTM, members from the Biomedical Engineering and Biological Implants Committees work on standards for devices, biologics, and tissue engineered medical products. ASTM has hosted workshops and symposia on the critical issues of metal-on-metal total hip replacement devices and modularity and tapers in joint replacement devices. At the 2014 AAOS Annual Meeting, the Biomedical Engineering Committee, in collaboration with the Biological Implants Committee, is proud to present two scientific exhibits:
- SE14 - Modularity in Orthopaedic Devices: At What Cost?
Modularity is a necessity in reconstructive procedures but at the cost of debris from corrosion/wear. This exhibit reviews those issues and the standards developed to assure safe and effective devices.
- SE 67 – A Call To Arms: Standards Determine Medical Device Availability & Surgeons Must Contribute to the Process!
Medical devices have undergone standards testing for years but now clinical trials and outcome measures are being drafted to improve and standardize clinical research.
AAOS Updates CPG on Treatment of OA Knee
The Clinical Practice Guideline (CPG) on the Treatment of Osteoarthritis of the Knee—2nd edition was approved by the AAOS Board of Directors at their meeting on May 18, 2013. This guideline replaces the 2008 AAOS CPG, and contains 15 recommendations on the nonsurgical treatment of OA of the knee. Although the 2013 CPG contains the same topics found in the first edition, the work group revised the search inclusion criteria to consider only primary research articles with a sample size of at least 30 participants and a follow-up period of at least 4 weeks. One significant recommendation change from the previous CPG is regarding the issue of viscosupplementation: in 2008, AAOS had an "inconclusive" recommendation, while the 2013 guideline states, "We cannot recommend using hyaluronic acid for patients with symptomatic osteoarthritis of the knee." This recommendation is rated "strong" based on supporting evidence from three high-quality and 11 moderate-quality research studies that met the inclusion criteria. To access the full guideline document please visit http://www.aaos.org/oakcpg
- AAOS Approves Updated OA Knee CPG by David S. Jevsevar, MD, MBA (AAOS Now, June 2013)
Recent and Upcoming Programs
- View all Research Symposia
- Research Capitol Hill Days
- AAOS/ORS/OREF Clinician Scientist Development Program
Resources for Specialty Societies
The AAOS Department of Research and Scientific Affairs has created a chart detailing the tools and resources currently available to facilitate research and quality activities within the Specialty Societies.
Evidence Based Medicine
- Evidence Based Medicine Information
- Appropriate Use Criteria
- Clinical Practice Guidelines
- Outcomes Instruments and Information
- Technology Overviews
Awards & Opportunities
Research Council & Committees
- Council on Research and Quality
- Biological Implants
- Biomedical Engineering
- Evidence-Based Quality and Value
- Patient Safety
- Research Development
Visit www.oref.org to learn how OREF has improved the way you practice.